O

Omega Research Group | Omega Research Maitland, LLC

Research site
(Unclaimed)
Location
7912 Forest City Road Suite 101, Orlando, Florida, United States of America

Site insights

Top conditions

Top treatments

Ozanimod
CVC
IW-1701
Itolizumab
EQ001
Cenicriviroc
PF-05221304
PF-06835375
PF-06865571
Olinciguat

Parent organization

This site is a part of Omega Research Group

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials
Locations recently updated

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.

Enrolling
Crohn Disease
Other: Placebo
Drug: Ozanimod

This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.

Enrolling
Crohn Disease
Drug: Ozanimod

Trial sponsors

Celgene logo
Pfizer logo
C
E
Mylan logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems